John J. Gormally serves as Executive at Akers Biosciences Inc, where they oversee executive responsibilities. Since joining the company, John J. Gormally has executed 9 insider transactions totaling $5.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 17, 2017 involved receiving (via award) 150,000 shares valued at $132.0K.
John J. Gormally currently holds 180,000 shares of Akers Biosciences Inc (AKER), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John J. Gormally has been a net buyer of AKER stock. They have purchased $5.6K and sold $0 worth of shares.
John J. Gormally's most recent insider trade was on Oct 17, 2017, when they sold 150,000 shares at $0.88 per share.
Get notified when new Form 4 filings are submitted
| $0.88 |
| Discretionary |
| Jun 8, 2016 | AKER | $54.7K | Award | 27,500 | $1.99 | Discretionary |
| Jun 8, 2016 | AKER | $54.7K | Gift | 27,500 | $1.99 | Discretionary |
| May 24, 2016 | AKER | $151 | Purchase | 69 | $2.19 | Discretionary |
| May 24, 2016 | AKER | $2.5K | Purchase | 1,131 | $2.25 | Discretionary |
| May 24, 2016 | AKER | $448 | Purchase | 200 | $2.24 | Discretionary |
| May 24, 2016 | AKER | $2.2K | Purchase | 1,000 | $2.20 | Discretionary |
| May 24, 2016 | AKER | $223 | Purchase | 100 | $2.23 | Discretionary |